Results 141 to 150 of about 298,741 (199)

Trends in the Utilization of Human Papillomavirus Vaccines and the Incidence of Malignant Cervical Cancer in Women and Teenagers: A Secondary Analysis. [PDF]

Healthcare (Basel), 2022
Luna M, Upadhyay S.
europepmc   +1 more source

Response to LTE: Clinical Considerations on HPV Knowledge, Screening, and Vaccination in Brazilian Primary Care

Health Science Reports, Volume 9, Issue 10, October 2026.
Alessandra Monteiro Ramos, Cláudia Vicari Bolignani, Leila Bernarda Donato Göttems, Ana Maria Costa, Heleno Rodrigues Corrêa Filho, Wania Maria do Espírito Santo Carvalho, Fábio Ferreira Amorim   +6 more
wiley   +1 more source

Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use

Signal Transduction and Targeted Therapy
Human papillomaviruses, particularly high-risk human papillomaviruses, have been universally considered to be associated with the oncogenesis and progression of various cancers.
Yu Zhang, Ke Qiu, Jianjun Ren, Yu Zhao, Ping Cheng   +4 more
doaj   +1 more source

The Role of Healthcare Providers in Promoting Human Papillomavirus Vaccines among Men Who Have Sex with Men: A Scoping Review. [PDF]

Vaccines (Basel), 2022
Chin KY, Ekeuku SO, Hamzah MR.
europepmc   +1 more source

Mothers' preferences and willingness-to-pay for human papillomavirus vaccines in Iran: A discrete choice experiment study. [PDF]

Prev Med Rep, 2021
Sargazi N, Takian A, Yaseri M, Daroudi R, Ghanbari Motlagh A, Nahvijou A, Zendehdel K.   +6 more
europepmc   +1 more source

Preclinical Assessment of a New Virus-like Particle-Based Quadrivalent Human Papillomavirus Vaccine in Animal Models

Background: A quadrivalent HPV vaccine (BPV) has been developed to prevent diseases caused by HPV types 6, 11, 16, and 18 for the first time in Iran. The BPV is composed of the papillomavirus major capsid protein L1, which serves as the primary target in
Hajar Mohammadi Barzelighi, Taqavian, Mohammad, Mohammad Taqavian, Hasan Jalili, Abbaszadeh, Payam, Babak Javadimehr, Payam Abbaszadeh, Mohammadi Barzelighi, Hajar, Javadimehr, Babak, Zahra Naderi Saffar, Naderi Saffar, Zahra, Safaeian, Mansooreh, Jalili, Hasan, Erfan Pakatchian, Mansooreh Safaeian, Pakatchian, Erfan   +15 more
core   +1 more source

Improving the Acceptability of Human Papillomavirus Vaccines Among Men Who Have Sex With Men According to the Associated Factors: A Systematic Review and Meta-analysis. [PDF]

Front Pharmacol, 2021
Zhao Y, Xin X, Deng H, Xu J, Weng W, Zhang M, Li J, Gao Y, Huang X, Liu C.   +9 more
europepmc   +1 more source

Real-world safety data of human papillomavirus vaccines after marketing in Shandong, China, August 2017-October 2025. [PDF]

Hum Vaccin Immunother
Xie M, Li H, Qiu X, Kang X, Wei J, Liu S, Tao Z, Zhang Y.   +7 more
europepmc   +1 more source

Immunogenicity, efficacy, and safety of different dose schedules of human papillomavirus vaccines: a Bayesian network meta-analysis of randomized controlled trials. [PDF]

Front Immunol
Ye J, Zhu ZQ, Wang F, Chen Y, Xie DY, He XF.   +5 more
europepmc   +1 more source

Exceeding expectations: factors contributing to the potency of human papillomavirus vaccines. [PDF]

Lancet Microbe
Schiller JT, Kines RC, Day PM, Çuburu N, Kreimer AR, Lowy DR.   +5 more
europepmc   +1 more source